Xu Y, Ding K, Peng Z, Ding L, et al. Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts. Mol Cancer Ther 2024;23:733-742.
PMID: 38346938